Consolidated Statement of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Operating activities
Net income (loss)	$ (49)	$ 48	$ (311)
Depreciation	401	393	365
Amortization	21	23	23
Amortization of deferred financing charges	6	5	5
Write-off of deferred financing costs		1
Earnings of affiliates, net of dividends received	(7)	11	23
Stock compensation expense	30	26	19
Deferred income taxes	(29)	(104)	153
Pension expense, net	1	3	(1)
Impairment of goodwill			191
Change in working capital	27	70	199
Loss on disposal group previously held for sale	26
Change in other noncurrent assets and liabilities	25	11	9
Other, net	(2)	(11)	(26)
Net cash provided by operating activities	450	476	649
Investing activities
Purchases of property, plant and equipment	(380)	(501)	(440)
Proceeds from sale of property, plant and equipment	11	2	3
Purchases of marketable securities			(15)
Proceeds from maturities of marketable securities			30
Settlements of undesignated derivatives	(5)	(13)	(8)
Other, net	22	(16)	4
Net cash used in investing activities	(352)	(528)	(426)
Financing activities
Net change in short-term debt	(14)	(30)	33
Proceeds from long-term debt	1	458	2
Repayment of long-term debt	(37)	(209)	(24)
Deferred financing payments		(9)
Dividends paid to common stockholders	(58)	(58)	(58)
Repurchases of common stock			(25)
Distributions to noncontrolling interests	(20)	(10)	(9)
Collection of note receivable from redeemable noncontrolling interest	11
Contributions from redeemable noncontrolling interests	18	22	51
Payments to acquire noncontrolling interests			(4)
Other, net	9	(4)	(8)
Net cash provided by (used in) financing activities	(90)	160	(42)
Net increase in cash, cash equivalents and restricted cash	8	108	181
Cash, cash equivalents and restricted cash - beginning of period	563	442	287
Effect of exchange rate changes on cash balances	(59)	13	(26)
Cash, cash equivalents and restricted cash - end of period	$ 512	$ 563	$ 442